Related Experiment Video

Updated: Jan 21, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

12.0K

Nanoparticle Interactions with the Tumor Microenvironment

Yanyan Huai, Md Nazir Hossen, Stefan Wilhelm1

  • 1Stephenson School of Biomedical Engineering , University of Oklahoma , Norman , Oklahoma 73072 , United States.

Bioconjugate Chemistry
|August 14, 2019
PubMed

Insights

The tumor microenvironment (TME) presents unique characteristics exploitable for cancer therapy. This review explores nanoparticle (NP) interactions with the TME, highlighting challenges and strategies for effective nanomedicine.

Area of Science:

  • Oncology
  • Materials Science
  • Biomedical Engineering

Background:

  • The tumor microenvironment (TME) exhibits distinct features like hypoxia, acidosis, and abnormal vasculature compared to normal tissues.
  • These aberrant TME characteristics offer potential targets for developing novel anticancer therapies.
  • Nanoparticle (NP)-based drug delivery systems are increasingly investigated for cancer treatment.

Purpose of the Study:

  • To review the composition and pathophysiology of the TME.
  • To introduce nanoparticles (NPs) utilized in cancer therapy.
  • To discuss the interactions between the TME and NPs, and outline challenges and strategies for TME-based nanotherapy.

Main Methods:

  • Literature review of TME characteristics and nanoparticle applications in cancer.
  • Analysis of TME-NP interactions.
  • Identification of challenges and potential solutions for nanotherapy targeting the TME.

Main Results:

  • The TME possesses unique physicochemical properties that can be leveraged for targeted drug delivery.
  • Various NPs have been designed to interact with specific TME components or overcome its barriers.
  • Significant challenges remain in achieving efficient NP delivery and therapeutic efficacy within the TME.

Conclusions:

  • Understanding TME pathophysiology is crucial for designing effective nanotherapeutics.
  • Exploiting TME anomalies with NPs holds promise for improved cancer treatment outcomes.
  • Overcoming TME-related challenges is key to advancing nanomedicine for cancer therapy.

More Related Videos

Viral Nanoparticles for In vivo Tumor Imaging14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

17.8K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

10.3K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Predator-Prey Interactions02:39

Predator-Prey Interactions

Predators consume prey for energy. Predators that acquire prey and prey that avoid predation both increase their chances of survival and reproduction (i.e., fitness). Routine predator-prey interactions elicit mutual adaptations that improve predator offenses, such as claws, teeth, and speed, as well as prey defenses, including crypsis, aposematism, and mimicry. Thus, predator-prey interactions resemble an evolutionary arms race.
21.1K
Van der Waals Interactions01:24

Van der Waals Interactions

Atoms and molecules interact with each other through intermolecular forces. These electrostatic forces arise from attractive or repulsive interactions between particles with permanent, partial, or temporary charges. The intermolecular forces between neutral atoms and molecules are ion–dipole, dipole–dipole, and dispersion forces, collectively known as van der Waals forces.
70.7K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K